TYK MEDICINES-B (02410): H shares fully tradable approved for listing

TYK MEDICINES-B (02410) announced that the company has applied to the Listing Committee of the Stock Exchange for approval to convert 1.74 billion shares of non-listed shares held by 25 shareholders of the company into 1.74 billion H shares (converted H shares) for listing and trading (listing approval). The company is pleased to announce that the Stock Exchange has granted the listing approval on February 10, 2025.